重组Anti-RAB7抗体[EPR7588(B)] - Late Endosome Marker
Anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker
- KO Validated
- RabMAb
- Lab Essentials
- 了解详情
5
(1 Review)
|
(17 Publications)
Anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker (ab126712) is a rabbit monoclonal antibody detecting RAB7 in Western Blot, IHC-P. Suitable for Human, Mouse, Rat.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
查看别名
RAB7, RAB7A, Ras-related protein Rab-7a
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker (AB126712)
Immunohistochemical analysis of paraffin-embedded Human colon adenocarcinoma tissue labelling Rab7A with unpurified ab126712 at dilution of 1/50.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker (AB126712)
All lanes:
Western blot - Anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker (ab126712) at 1/1000 dilution
Lane 1:
A375 cell lysate at 10 µg
Lane 2:
A431 cell lysate at 10 µg
Lane 3:
HACAT cell lysate at 10 µg
Lane 4:
Human fetal brain lysate at 10 µg
Lane 5:
B16F0 cell lysate at 10 µg
Lane 6:
C6 cell lysate at 10 µg
Secondary
All lanes:
Goat anti-Rabbit HRP at 1/2000 dilution
false
- WB
Unknown
Western blot - Anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker (AB126712)
Blocking and diluting buffer 5% NFDM/TBST
All lanes:
Western blot - Anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker (ab126712) at 1/1000 dilution
Lane 1:
A375 whole cell lysate at 20 µg
Lane 2:
A431 whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 23 kDa
false
- WB
Unknown
Western blot - Anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker (AB126712)
Blocking and diluting buffer 5% NFDM/TBST
All lanes:
Western blot - Anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker (ab126712) at 1/1000 dilution
Lane 1:
C6 (rat glioma) whole cell lysate at 20 µg
Lane 2:
Raw264.7 (mouse abelson murine leukemia virus-induced tumor) whole cell lysate at 20 µg
Lane 3:
NIH/3T3 (mouse embryo) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 35 kDa,36 kDa
Observed band size: 23 kDa
false
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker (AB126712)
Immunohistochemical staining of paraffin-embedded human bladder carcinoma sections labelling RAB7 with purified ab126712 at dilution of 1/70. The secondary antibody used was ab97051; a goat anti-rabbit IgG H&L (HRP) at dilution of 1/500. The sample was counter-stained with hematoxylin. Antigen retrieval was performed using EDTA Buffer; pH 9.0. PBS was used instead of the primary antibody as the negative control and is shown in the inset.
- WB
Lab
Western blot - Anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker (AB126712)
Lanes 1 - 2 : Merged signal (red and green). Green - ab126712 observed at 23 kDa. Red - loading control ab7291 (Mouse anti-Alpha Tubulin [DM1A]) observed at 55 kDa.
ab126712 was shown to react with RAB7 in wild-type HeLa cells in Western blot with loss of signal observed in RAB7A knockout cell line ab255423 (RAB7A knockout cell lysate ab263831). Wild-type HeLa and RAB7A knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3 % milk in TBS-T (0.1 % Tween®) before incubation with ab126712 and ab7291 (Mouse anti-Alpha Tubulin [DM1A]) overnight at 4 °C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker (ab126712) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
RAB7A knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human RAB7A (RAB7) knockout HeLa cell line (<a href='/products/cell-lines/human-rab7a-rab7-knockout-hela-cell-line-ab255423'>ab255423</a>)
Observed band size: 23 kDa
false
- WB
Lab
Western blot - Anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker (AB126712)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : RAB7 knockout HAP1 cell lysate (20 μg)
Lane 3 : A431 cell lysate (20 μg)
Lane 4 : Human fetal brain tissue lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab126712 observed at 24 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab126712 was shown to recognize RAB7 when RAB7 knockout samples were used, along with additional cross-reactive bands. Wild-type and RAB7 knockout samples were subjected to SDS-PAGE. ab126712 and ab8245 (loading control to GAPDH) were diluted 1/1000 and 1/10000 and incubated overnight at 4°C. Blots were developed withGoat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker (ab126712)
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker (AB126712)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
- WB
CiteAb
Western blot - Anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker (AB126712)
RAB7 western blot using anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker ab126712. Publication image and figure legend from Li, M., Zhang, D., et al., 2020, Front Microbiol, PubMed 32210929.
ab126712 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab126712 please see the product overview.
Effects of Rab5 and Rab7 knockdown on Zika virus (ZIKV) infection. (A) The knockdown efficiency of Rab5 or Rab7 was determined by Western blot. T98G cells were transfected with either siControl, siRab5, or siRab7 for 48 h. Cell lysates were reacted with an anti-Rab5 antibody or an anti-Rab7 antibody specific for the indicated proteins. β-actin was used as an internal loading control. One representative experiment out of three is shown. (B) Rab5 or Rab7 depletion reduced ZIKV propagation. T98G cells transfected with the indicated siRNAs were infected with ZIKV at a multiplicity of infection (MOI) of 0.5 and incubated for 48 h to allow virus propagation. The infected cells were lysed to quantitate viral RNA copy numbers by RT-qPCR. (C) At 48 h post-infection, the titers of supernatant viruses were determined by plaque assay. (D) ZIKV localized in Rab5- and Rab7-postitive endosomes. T98G cells were transfected with EGFP-tagged Rab5 or Rab7 for 24 h, followed by infection with ZIKV at an MOI of 10 at 4°C for 1 h and then shifted to 37°C. At 24 h post-infection, the cells were fixed and stained with an anti-ZIKV envelop antibody (red). Nuclei were stained with DAPI (blue). One representative experiment out of three is shown (A). The immunofluorescence was examined under a confocal microscope. Representative confocal images from three independent experiments are shown. Scale bars in all panels represent 10 μm (D). The data shown are the mean ± SD of three independent experiments (B,C). *p < 0.05; **p < 0.01; ***p < 0.001.
false
不同偶联物与剂型 (10)
-
Anti-RAB7 antibody [EPR7588(B)] - BSA and Azide free
-
660 APC
APC Anti-RAB7 antibody [EPR7588(B)] (Late Endosome Marker)
-
HRP Anti-RAB7 antibody [EPR7588(B)] (Late Endosome Marker)
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker
-
578 PE
PE Anti-RAB7 antibody [EPR7588(B)] (Late Endosome Marker)
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker
反应性数据
产品详情
What is this antibody validated in?
Anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker (ab126712) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat samples.
What is the molecular weight of RAB7?
Anti-RAB7 [EPR7588(B)] - Late Endosome Marker (ab126712) specifically detects a band for RAB7 (UniProt: P51149) at a molecular weight of 23kDa.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-RAB7 antibody [EPR7588(B)] - Late Endosome Marker (ab126712) has been confirmed by Western blot testing in RAB7A Knockout HAP1 cell line, ab255423.
Other related products
We have a range of other formats of antibody clone [EPR7588(B)] also available for your convenience: ab126712, Carrier free - ab238990, PE - ab305749, APC - ab305750, HRP - ab305751, Alkaline Phosphatase - ab308821, Alexa Fluor® 488 - ab309763, Alexa Fluor® 647 - ab310133, Alexa Fluor® 594 - ab310554, Alexa Fluor® 555 - ab312083, Alexa Fluor® 568 - ab312561, Alexa Fluor® 750 - ab321009
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
RAB7 affects various processes including autophagy cell signaling and pathogen infection response. It often functions as part of the endosomal machinery and forms complexes with other proteins like RAB3GAP1 and RILP. These complexes help mediate vesicle transport and membrane trafficking processes which are essential for the maintenance of cellular homeostasis. RAB7 is significant in ensuring proper lysosomal positioning and function which is critical for cellular metabolism and degradation.
Pathways
RAB7 integrates into the endocytic and autophagic pathways by facilitating the transport between endosomes and lysosomes. It connects with the PI3K/AKT pathway impacting cell proliferation and survival. RAB7 also interacts with the retromer complex influencing the retrieval of receptors from endosomes. Proteins like FYCO1 and Prostaglandin E2 synthase can also cooperate with RAB7 in these pathways further establishing its role in cellular dynamics and signaling.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (17)
Recent publications for all applications. Explore the full list and refine your search
Science advances 11:eady6386 PubMed40991712
2025
Applications
Unspecified application
Species
Unspecified reactive species
Translational neurodegeneration 13:54 PubMed39497162
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of medical virology 96:e29730 PubMed38860570
2024
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 10:eadh3409 PubMed38277448
2024
Applications
Unspecified application
Species
Unspecified reactive species
Small (Weinheim an der Bergstrasse, Germany) 19:e2204293 PubMed36965074
2023
Applications
Unspecified application
Species
Unspecified reactive species
Biomaterials science 11:263-277 PubMed36440740
2022
Applications
Unspecified application
Species
Unspecified reactive species
iScience 25:105444 PubMed36310646
2022
Applications
Unspecified application
Species
Unspecified reactive species
Anesthesia and analgesia 136:779-788 PubMed35880774
2022
Applications
Unspecified application
Species
Unspecified reactive species
Biomacromolecules 23:2586-2594 PubMed35641881
2022
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 12:4980 PubMed35322139
2022
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com